vs
Digimarc CORP（DMRC）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
SUTRO BIOPHARMA, INC.的季度营收约是Digimarc CORP的1.3倍（$11.6M vs $8.9M），Digimarc CORP同比增速更快（2.9% vs -21.4%），过去两年Digimarc CORP的营收复合增速更高（-5.3% vs -5.4%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
DMRC vs STRO — 直观对比
营收规模更大
STRO
是对方的1.3倍
$8.9M
营收增速更快
DMRC
高出24.2%
-21.4%
两年增速更快
DMRC
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $11.6M |
| 净利润 | $-4.2M | — |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | — |
| 净利率 | -47.2% | — |
| 营收同比 | 2.9% | -21.4% |
| 净利润同比 | 51.4% | 35.4% |
| 每股收益（稀释后） | $-0.18 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCSTRO
| Q4 25 | $8.9M | $11.6M | ||
| Q3 25 | $7.6M | $9.7M | ||
| Q2 25 | $8.0M | $63.7M | ||
| Q1 25 | $9.4M | $17.4M | ||
| Q4 24 | $8.7M | $14.8M | ||
| Q3 24 | $9.4M | $8.5M | ||
| Q2 24 | $10.4M | $25.7M | ||
| Q1 24 | $9.9M | $13.0M |
净利润DMRCSTRO
| Q4 25 | $-4.2M | — | ||
| Q3 25 | $-8.2M | $-56.9M | ||
| Q2 25 | $-8.2M | $-11.5M | ||
| Q1 25 | $-11.7M | $-76.0M | ||
| Q4 24 | $-8.6M | $-72.4M | ||
| Q3 24 | $-10.8M | $-48.8M | ||
| Q2 24 | $-9.3M | $-48.0M | ||
| Q1 24 | $-10.3M | $-58.2M |
毛利率DMRCSTRO
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCSTRO
| Q4 25 | -48.2% | — | ||
| Q3 25 | -109.7% | -499.9% | ||
| Q2 25 | -105.2% | -5.2% | ||
| Q1 25 | -128.9% | -393.8% | ||
| Q4 24 | -105.1% | -440.7% | ||
| Q3 24 | -120.4% | -797.2% | ||
| Q2 24 | -96.2% | -189.4% | ||
| Q1 24 | -109.2% | -435.0% |
净利率DMRCSTRO
| Q4 25 | -47.2% | — | ||
| Q3 25 | -106.9% | -586.6% | ||
| Q2 25 | -102.6% | -18.0% | ||
| Q1 25 | -125.2% | -436.6% | ||
| Q4 24 | -99.9% | -489.2% | ||
| Q3 24 | -113.9% | -572.6% | ||
| Q2 24 | -89.3% | -186.8% | ||
| Q1 24 | -104.0% | -447.5% |
每股收益（稀释后）DMRCSTRO
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.38 | $-0.67 | ||
| Q2 25 | $-0.38 | $-0.14 | ||
| Q1 25 | $-0.55 | $-0.91 | ||
| Q4 24 | $-0.40 | $-27.63 | ||
| Q3 24 | $-0.50 | $-0.59 | ||
| Q2 24 | $-0.43 | $-0.59 | ||
| Q1 24 | $-0.50 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $-132.5M |
| 总资产 | $53.0M | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCSTRO
| Q4 25 | $12.9M | $141.4M | ||
| Q3 25 | $12.6M | $167.6M | ||
| Q2 25 | $16.1M | $205.1M | ||
| Q1 25 | $21.6M | $249.0M | ||
| Q4 24 | $28.7M | $316.9M | ||
| Q3 24 | $33.7M | $388.3M | ||
| Q2 24 | $41.5M | $375.6M | ||
| Q1 24 | $48.9M | $267.6M |
股东权益DMRCSTRO
| Q4 25 | $40.2M | $-132.5M | ||
| Q3 25 | $41.4M | $-87.3M | ||
| Q2 25 | $46.5M | $-32.1M | ||
| Q1 25 | $50.0M | $-25.8M | ||
| Q4 24 | $61.4M | $44.6M | ||
| Q3 24 | $70.2M | $111.2M | ||
| Q2 24 | $77.2M | $152.2M | ||
| Q1 24 | $84.5M | $98.0M |
总资产DMRCSTRO
| Q4 25 | $53.0M | $173.8M | ||
| Q3 25 | $55.4M | $209.7M | ||
| Q2 25 | $60.7M | $262.4M | ||
| Q1 25 | $66.5M | $321.4M | ||
| Q4 24 | $75.8M | $387.2M | ||
| Q3 24 | $85.0M | $451.8M | ||
| Q2 24 | $93.4M | $489.0M | ||
| Q1 24 | $99.7M | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | — |
8季度趋势，按日历期对齐
经营现金流DMRCSTRO
| Q4 25 | $991.0K | $-177.2M | ||
| Q3 25 | $-2.6M | $-38.2M | ||
| Q2 25 | $-4.7M | $-44.7M | ||
| Q1 25 | $-5.5M | $-67.9M | ||
| Q4 24 | $-4.2M | $-71.7M | ||
| Q3 24 | $-7.1M | $-64.5M | ||
| Q2 24 | $-6.8M | $9.5M | ||
| Q1 24 | $-8.4M | $-64.7M |
自由现金流DMRCSTRO
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | $-5.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-7.2M | — | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $-8.5M | — |
自由现金流率DMRCSTRO
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | — | ||
| Q2 25 | -61.0% | — | ||
| Q1 25 | -59.1% | — | ||
| Q4 24 | -49.1% | — | ||
| Q3 24 | -75.7% | — | ||
| Q2 24 | -66.1% | — | ||
| Q1 24 | -85.8% | — |
资本支出强度DMRCSTRO
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.1% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
STRO
暂无分部数据
